The U.S. Food and Drug Administration has approved the first-in-class TRPM8 receptor agonist Tryptyr (acoltremon ophthalmic solution) for the treatment of signs and symptoms of dry eye disease.
Researchers have harnessed one of nature's most spectacular power conversions–photosynthesis, in which light is used to ...
What if eyes could use light to heal themselves? Drawing inspiration from how plants harness sunlight, researchers at the ...
NUS scientists have developed a novel treatment for dry eye disease by harnessing the power of photosynthesis in corneal cells. Read more at straitstimes.com. Read more at straitstimes.com.
Vietnam Investment Review on MSN
NUS scientists plant a cure for dry eye disease using photosynthesis
SINGAPORE, May 16, 2026 /PRNewswire/ -- What if your eyes could use light to heal themselves? Drawing inspiration from how plants harness sunlight, researchers at the National University of Singapore ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results